Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.710
-0.010 (-0.27%)
At close: Nov 26, 2025, 4:00 PM EST
3.718
+0.008 (0.20%)
After-hours: Nov 26, 2025, 7:49 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2020
Period Ending
Dec '24 Dec '20
Genetic Therapies
2.98M
Log In
Genetic Therapies Growth
-42.74%
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2020
Period Ending
Dec '24 Dec '20
United States
2.98M
Log In
United States Growth
-42.74%
Log In